Approaches for Analyzing the Roles of Mast Cells and Their Proteases In Vivo

Advances in Immunology

Volumn 126, Issue , 2015, Pages 45-127

  Galli, Stephen J ^a   Tsai, Mindy ^a   Marichal, Thomas ^a,b   Tchougounova, Elena ^c   Reber, Laurent L ^a   Pejler, Gunnar ^d,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Basophils; C kit; Cre recombinase; Mouse model; Stem cell factor

Indexed keywords

APC 2059; CHYMASE INHIBITOR; IMMUNOGLOBULIN G; MASITINIB; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; N (1 HYDROXY 2 NAPHTHOYL)ARGINYLPROLINAMIDE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE; TRYPTASE INHIBITOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN E; PEPTIDE HYDROLASE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLERGIC CONJUNCTIVITIS; ALLERGIC ENCEPHALOMYELITIS; ANAPHYLAXIS; ANIMAL HUSBANDRY; ARTHRITIS; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL POPULATION; CELL RENEWAL; CELL SURVIVAL; CELL THERAPY; CELLULAR DISTRIBUTION; CPA3 GENE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EXPERIMENTAL GLOMERULONEPHRITIS; GENE; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE STRUCTURE; HUMAN; IL 10 GENE; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; INNATE IMMUNITY; MAST CELL; MAST CELL DEGRANULATION; MICROBIOME; NEMATODIASIS; NONHUMAN; ONCOGENE C KIT; PHARMACOLOGICAL BLOCKING; PHENOTYPE; POISONOUS ANIMAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ALLERGY; ULCERATIVE COLITIS; WOUND HEALING; ANIMAL; CLASSIFICATION; DISEASE MODEL; ENZYMOLOGY; IMMUNOLOGY; MOUSE; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; MICE; PEPTIDE HYDROLASES;

EID: 84923273109     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/bs.ai.2014.11.002     Document Type: Chapter

References (320)

1. Abe T., Nawa Y. Localization of mucosal mast cells in W/Wv mice after reconstitution with bone marrow cells or cultured mast cells, and its relation to the protective capacity to Strongyloides ratti infection. Parasite Immunology 1987, 9:477.
2. Abonia J.P., Friend D.S., Austen W.G., Moore F.D., Carroll M.C., Chan R., et al. Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. Journal of Immunology 2005, 174:7285.
3. Abraham S.N., St John A.L. Mast cell-orchestrated immunity to pathogens. Nature Reviews Immunology 2010, 10:440.
4. Åbrink M., Grujic M., Pejler G. Serglycin is essential for maturation of mast cell secretory granule. The Journal of Biological Chemistry 2004, 279:40897.
5. Akahoshi M., Song C.H., Piliponsky A.M., Metz M., Guzzetta A., Abrink M., et al. Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. The Journal of Clinical Investigation 2011, 121:4180.
6. Andersson M.K., Pemberton A.D., Miller H.R., Hellman L. Extended cleavage specificity of mMCP-1, the major mucosal mast cell protease in mouse-high specificity indicates high substrate selectivity. Molecular Immunology 2008, 45:2548.
7. d mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. The Journal of Clinical Investigation 1993, 92:1639.
8. Ando T., Xiao W., Gao P., Namiranian S., Matsumoto K., Tomimori Y., et al. Critical role for mast cell Stat5 activity in skin inflammation. Cell Reports 2014, 6:366.
9. Antsiferova M., Martin C., Huber M., Feyerabend T.B., Forster A., Hartmann K., et al. Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis. Journal of Immunology 2013, 191:6147.
10. Arac A., Grimbaldeston M., Nepomuceno A.R.B., Olayiwola O., Pereira M.P., Nishiyama Y., et al. Evidence that meningeal mast cells can worsen stroke pathology in mice. The American Journal of Pathology 2014, 184:2493-2504.
11. Arias K., Chu D.K., Flader K., Botelho F., Walker T., Arias N., et al. Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice. The Journal of Allergy and Clinical Immunology 2011, 127:1552.
12. i3. Science 1993, 262:1569.
13. Arizono N., Kasugai T., Yamada M., Okada M., Morimoto M., Tei H., et al. Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats. Blood 1993, 81:2572.
14. Arumugam T., Ramachandran V., Logsdon C.D. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. Journal of the National Cancer Institute 2006, 98:1806.
15. d mast cell-deficient mice. Journal of Immunology 1983, 131:2687.
16. Bankova L.G., Lezcano C., Pejler G., Stevens R.L., Murphy G.F., Austen K.F., et al. Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions. Journal of Immunology 2014, 192:2812.
17. Becker M., Reuter S., Friedrich P., Doener F., Michel A., Bopp T., et al. Genetic variation determines mast cell functions in experimental asthma. Journal of Immunology 2011, 186:7225.
18. Beghdadi W., Madjene L.C., Claver J., Pejler G., Beaudoin L., Lehuen A., et al. Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction. Kidney International 2013, 84:317.
19. Bennett J.L., Blanchet M.R., Zhao L., Zbytnuik L., Antignano F., Gold M., et al. Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. Journal of Immunology 2009, 182:5507.
20. Berlin A.A., Hogaboam C.M., Lukacs N.W. Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. Laboratory Investigation 2006, 86:557.
21. Berlin A.A., Lincoln P., Tomkinson A., Lukacs N.W. Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses. Clinical and Experimental Immunology 2004, 136:15.
22. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. The Journal of Experimental Medicine 2000, 192:1441.
23. Blank U., Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends in Immunology 2004, 25:266.
24. + regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice. PLoS Pathogens 2014, 10:e1003913.
25. -/- mice. Cardiovascular Research 2011, 89:244.
26. Bowie M.B., Kent D.G., Copley M.R., Eaves C.J. Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells. Blood 2007, 109:5043.
27. Boyce J.A. Mast cells and eicosanoid mediators: A system of reciprocal paracrine and autocrine regulation. Immunological Reviews 2007, 217:168.
28. Braga T., Grujic M., Lukinius A., Hellman L., Abrink M., Pejler G. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. The Biochemical Journal 2007, 403:49.
29. Brandt E.B., Strait R.T., Hershko D., Wang Q., Muntel E.E., Scribner T.A., et al. Mast cells are required for experimental oral allergen-induced diarrhea. The Journal of Clinical Investigation 2003, 112:1666.
30. Brown M.A., Hatfield J.K. Mast cells are important modifiers of autoimmune disease: With so much evidence, why is there still controversy?. Frontiers in Immunology 2012, 3:147.
31. Brusselle G.G., Kips J.C., Tavernier J.H., van der Heyden J.G., Cuvelier C.A., Pauwels R.A., et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clinical and Experimental Allergy 1994, 24:73.
32. Bryce P.J., Miller M.L., Miyajima I., Tsai M., Galli S.J., Oettgen H.C. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 2004, 20:381.
33. Buch T., Heppner F.L., Tertilt C., Heinen T.J., Kremer M., Wunderlich F.T., et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nature Methods 2005, 2:419.
34. Caughey G.H. Tryptase genetics and anaphylaxis. The Journal of Allergy and Clinical Immunology 2006, 117:1411.
35. Caughey G.H. Mast cell proteases as protective and inflammatory mediators. Advances in Experimental Medicine and Biology 2011, 716:212.
36. Chan C.Y., St John A.L., Abraham S.N. Mast cell IL-10 drives localized tolerance in chronic bladder infection. Immunity 2013, 38:349.
37. v. Journal of Cellular Physiology 1969, 73:25.
38. Christy A.L., Walker M.E., Hessner M.J., Brown M.A. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. Journal of Autoimmunity 2013, 42:50.
39. Clark J.M., Abraham W.M., Fishman C.E., Forteza R., Ahmed A., Cortes A., et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. American Journal of Respiratory and Critical Care Medicine 1995, 152:2076.
40. Costanzo M.J., Yabut S.C., Zhang H.C., White K.B., de Garavilla L., Wang Y., et al. Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives. Bioorganic & Medicinal Chemistry Letters 2008, 18:2114.
41. Cozzi E., Ackerman K.G., Lundequist A., Drazen J.M., Boyce J.A., Beier D.R. The naïve airway hyperresponsiveness of the A/J mouse is Kit-mediated. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:12787.
42. Craig S.S., Schwartz L.B. Tryptase and chymase, markers of distinct types of human mast cells. Immunologic Research 1989, 8:130.
43. v mice. The Journal of Parasitology 1983, 69:66.
44. Czechowicz A., Kraft D., Weissman I.L., Bhattacharya D. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 2007, 318:1296.
45. Dawicki W., Marshall J.S. New and emerging roles for mast cells in host defence. Current Opinion in Immunology 2007, 19:31.
46. De Filippo K., Dudeck A., Hasenberg M., Nye E., van Rooijen N., Hartmann K., et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 2013, 121:4930.
47. €RI and FcγRIII for limiting amounts of FcR α and γ chains. The Journal of Clinical Investigation 1997, 99:915.
48. Donaldson L.E., Schmitt E., Huntley J.F., Newlands G.F., Grencis R.K. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. International Immunology 1996, 8:559.
49. Douaiher J., Succar J., Lancerotto L., Gurish M.F., Orgill D.P., Hamilton M.J., et al. Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Advances in Immunology 2014, 122:211.
50. Dubreuil P., Letard S., Ciufolini M., Gros L., Humbert M., Casteran N., et al. Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS One 2009, 4:e7258.
51. Dudeck A., Dudeck J., Scholten J., Petzold A., Surianarayanan S., Kohler A., et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011, 34:973.
52. Echtenacher B., Mannel D.N., Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75.
53. Egozi E.I., Ferreira A.M., Burns A.L., Gamelli R.L., Dipietro L.A. Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair and Regeneration 2003, 11:46.
54. Elliott E.R., Van Ziffle J.A., Scapini P., Sullivan B.M., Locksley R.M., Lowell C.A. Deletion of Syk in neutrophils prevents immune complex arthritis. Journal of Immunology 2011, 187:4319.
55. Enoksson M., Lyberg K., Moller-Westerberg C., Fallon P.G., Nilsson G., Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. Journal of Immunology 2011, 186:2523.
56. Erin E.M., Leaker B.R., Zacharasiewicz A., Higgins L.A., Nicholson G.C., Boyce M.J., et al. Effects of a reversible β-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses. Clinical and Experimental Allergy 2006, 36:458.
57. Fantozzi R., Brunelleschi S., Giuliattini L., Blandina P., Masini E., Cavallo G., et al. Mast cell and neutrophil interactions: A role for superoxide anion and histamine. Agents and Actions 1985, 16:260.
58. Fawcett D.W. Cytological and pharmacological observations on the release of histamine by mast cells. The Journal of Experimental Medicine 1954, 100:217.
59. Ferry X., Brehin S., Kamel R., Landry Y. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 2002, 23:1507.
60. Feyerabend T.B., Hausser H., Tietz A., Blum C., Hellman L., Straus A.H., et al. Loss of histochemical identity in mast cells lacking carboxypeptidase A. Molecular and Cellular Biology 2005, 25:6199.
61. Feyerabend T.B., Terszowski G., Tietz A., Blum C., Luche H., Gossler A., et al. Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsic mechanisms. Immunity 2009, 30:67.
62. Feyerabend T.B., Weiser A., Tietz A., Stassen M., Harris N., Kopf M., et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 2011, 35:832.
63. Finkelman F.D. Anaphylaxis: Lessons from mouse models. The Journal of Allergy and Clinical Immunology 2007, 120:506.
64. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999, 400:773.
65. Franco C.B., Chen C.C., Drukker M., Weissman I.L., Galli S.J. Distinguishing mast cell and granulocyte differentiation at the single-cell level. Cell Stem Cell 2010, 6:361.
66. Friend D.S., Ghildyal N., Austen K.F., Gurish M.F., Matsumoto R., Stevens R.L. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. The Journal of Cell Biology 1996, 135:279.
67. Furumoto Y., Charles N., Olivera A., Leung W.H., Dillahunt S., Sargent J.L., et al. PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability. Blood 2011, 118:5466.
68. Gagliani N., Hu B., Huber S., Elinav E., Flavell R.A. The fire within: Microbes inflame tumors. Cell 2014, 157:776.
69. Galli S.J., Borregaard N., Wynn T.A. Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nature Immunology 2011, 12:1035.
70. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity. Nature Reviews Immunology 2008, 8:478.
71. Galli S.J., Hammel I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 1984, 226:710.
72. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annual Review of Immunology 2005, 23:749.
73. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nature Immunology 2005, 6:135.
74. Galli S.J., Tsai M. IgE and mast cells in allergic disease. Nature Medicine 2012, 18:693.
75. Galli S.J., Tsai M., Wershil B.K., Tam S.Y., Costa J.J. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. International Archives of Allergy and Immunology 1995, 107:51.
76. Galli S.J., Zsebo K.M., Geissler E.N. The kit ligand, stem cell factor. Advances in Immunology 1994, 55:1.
77. Gaudenzio N., Espagnolle N., Mars L.T., Liblau R., Valitutti S., Espinosa E. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood 2009, 114:4979.
78. Gekara N.O., Weiss S. Mast cells initiate early anti-Listeria host defences. Cellular Microbiology 2008, 10:225.
79. Gerbaulet A., Wickenhauser C., Scholten J., Peschke K., Drube S., Horny H.P., et al. Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit. Blood 2011, 117:2012.
80. Gilfillan A.M., Beaven M.A. Regulation of mast cell responses in health and disease. Critical Reviews in Immunology 2011, 31:475.
81. Godfraind C., Louahed J., Faulkner H., Vink A., Warnier G., Grencis R., et al. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. Journal of Immunology 1998, 160:3989.
82. Gordon J.R., Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990, 346:274.
83. d genetically mast cell-deficient mice. Blood 1990, 75:1637.
84. Grayson M.H., Cheung D., Rohlfing M.M., Kitchens R., Spiegel D.E., Tucker J., et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. The Journal of Experimental Medicine 2007, 204:2759.
85. + regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008, 29:771.
86. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. The American Journal of Pathology 2005, 167:835.
87. Grimbaldeston M.A., Metz M., Yu M., Tsai M., Galli S.J. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Current Opinion in Immunology 2006, 18:751.
88. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunology 2007, 8:1095.
89. Grujic M., Calounova G., Eriksson I., Feyerabend T., Rodewald H.R., Tchougounova E., et al. Distorted secretory granule composition in mast cells with multiple protease deficiency. Journal of Immunology 2013, 191:3931.
90. Gurish M.F., Austen K.F. Developmental origin and functional specialization of mast cell subsets. Immunity 2012, 37:25.
91. Gushchin I.S., Miroshnikov A.I., Martynov V.I., Sviridov V.V. Histamine releasing and anti-inflammatory activities of MCD-peptide and its modified forms. Agents and Actions 1981, 11:69.
92. Ha T.Y., Reed N.D., Crowle P.K. Delayed expulsion of adult Trichinella spiralis by mast cell-deficient W/Wv mice. Infection and Immunity 1983, 41:445.
93. Haff L.A. Improved quantitative PCR using nested primers. PCR Methods and Applications 1994, 3:332.
94. Hallgren J., Karlson U., Poorafshar M., Hellman L., Pejler G. Mechanism for activation of mouse mast cell tryptase: Dependence on heparin and acidic pH for formation of active tetramers of mouse mast cell protease 6. Biochemistry 2000, 39:13068.
95. Hansbro P.M., Hamilton M.J., Fricker M., Gellatly S.L., Jarnicki A.G., Zheng D., et al. Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis. The Journal of Biological Chemistry 2014, 289:18214-18227.
96. Hansen C.H., Metzdorff S.B., Hansen A.K. Customizing laboratory mice by modifying gut microbiota and host immunity in an early "window of opportunity". Gut Microbes 2013, 4:241.
97. Hayashi S., Kunisada T., Ogawa M., Yamaguchi K., Nishikawa S. Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. Nucleic Acids Research 1991, 19:1267.
98. He S., Peng Q., Walls A.F. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: Selective enhancement of eosinophil recruitment by histamine. Journal of Immunology 1997, 159:6216.
99. He S., Walls A.F. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. British Journal of Pharmacology 1998, 125:1491.
100. He S., Walls A.F. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. European Journal of Pharmacology 1998, 352:91.
101. Heger K., Fierens K., Vahl J.C., Aszodi A., Peschke K., Schenten D., et al. A20-deficient mast cells exacerbate inflammatory responses in vivo. PLoS Biology 2014, 12:e1001762.
102. T2 expression from within the c-Kit gene locus allows efficient inducible gene targeting in and ablation of mast cells. European Journal of Immunology 2014, 44:296.
103. Heinrich M.C., Griffith D.J., Druker B.J., Wait C.L., Ott K.A., Zigler A.J. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 2000, 96:925.
104. Hellman L., Thorpe M. Granule proteases of hematopoietic cells, a family of versatile inflammatory mediators-An update on their cleavage specificity, in vivo substrates, and evolution. Biological Chemistry 2014, 395:15.
105. Hendrix S., Kramer P., Pehl D., Warnke K., Boato F., Nelissen S., et al. Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4. The FASEB Journal 2013, 27:920.
106. Hepworth M.R., Danilowicz-Luebert E., Rausch S., Metz M., Klotz C., Maurer M., et al. Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:6644.
107. Hershko A.Y., Suzuki R., Charles N., Alvarez-Errico D., Sargent J.L., Laurence A., et al. Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity 2011, 35:562.
108. Hill P.B., MacDonald A.J., Thornton E.M., Newlands G.F., Galli S.J., Miller H.R. Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: Activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology 1996, 87:326.
109. Hirai Y., Yasuhara T., Yoshida H., Nakajima T., Fujino M., Kitada C. A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. Chemical & Pharmaceutical Bulletin (Tokyo) 1979, 27:1942.
110. Hochegger K., Siebenhaar F., Vielhauer V., Heininger D., Mayadas T.N., Mayer G., et al. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. European Journal of Immunology 2005, 35:3074.
111. Honda K., Littman D.R. The microbiome in infectious disease and inflammation. Annual Review of Immunology 2012, 30:759.
112. Howell J.B., Altounyan R.E. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 1967, 2:539.
113. Huang R., Abrink M., Gobl A.E., Nilsson G., Aveskogh M., Larsson L.G., et al. Expression of a mast cell tryptase in the human monocytic cell lines U-937 and Mono Mac 6. Scandinavian Journal of Immunology 1993, 38:359.
114. Huang C., De Sanctis G.T., O'Brien P.J., Mizgerd J.P., Friend D.S., Drazen J.M., et al. Evaluation of the substrate specificity of human mast cell tryptase βI and demonstration of its importance in bacterial infections of the lung. The Journal of Biological Chemistry 2001, 276:26276.
115. Huang C., Friend D.S., Qiu W.T., Wong G.W., Morales G., Hunt J., et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. Journal of Immunology 1998, 160:1910.
116. Hubner G., Hu Q., Smola H., Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Developmental Biology 1996, 173:490.
117. Huizinga J.D., Thuneberg L., Kluppel M., Malysz J., Mikkelsen H.B., Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 1995, 373:347.
118. Humphries D.E., Wong G.W., Friend D.S., Gurish M.F., Qiu W.T., Huang C., et al. Heparin is essential for the storage of specific granule proteases in mast cells [see comments]. Nature 1999, 400:769.
119. Hunt J.E., Stevens R.L., Austen K.F., Zhang J., Xia Z., Ghildyal N. Natural disruption of the mouse mast cell protease 7 gene in the C57BL/6 mouse. The Journal of Biological Chemistry 1996, 271:2851.
120. Iba Y., Shibata A., Kato M., Masukawa T. Possible involvement of mast cells in collagen remodeling in the late phase of cutaneous wound healing in mice. International Immunopharmacology 2004, 4:1873.
121. Ikuta K., Weissman I.L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:1502.
122. Inoue N., Muramatsu M., Jin D., Takai S., Hayashi T., Katayama H., et al. Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice. Atherosclerosis 2009, 204:359.
123. Ito T., Smrz D., Jung M.Y., Bandara G., Desai A., Smrzova S., et al. Stem cell factor programs the mast cell activation phenotype. Journal of Immunology 2012, 188:5428.
124. Jawdat D.M., Rowden G., Marshall J.S. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. Journal of Immunology 2006, 177:1755.
125. Jippo T., Lee Y.M., Ge Y., Kim D.K., Okabe M., Kitamura Y. Tissue-dependent alteration of protease expression phenotype in murine peritoneal mast cells that were genetically labeled with green fluorescent protein. The American Journal of Pathology 2001, 158:1695.
126. Jippo T., Tsujino K., Kim H.M., Kim D.K., Lee Y.M., Nawa Y., et al. Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization. The American Journal of Pathology 1997, 150:1373.
127. Jogie-Brahim S., Min H.K., Fukuoka Y., Xia H.Z., Schwartz L.B. Expression of α-tryptase and β-tryptase by human basophils. The Journal of Allergy and Clinical Immunology 2004, 113:1086.
128. Juurikivi A., Sandler C., Lindstedt K.A., Kovanen P.T., Juutilainen T., Leskinen M.J., et al. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: A potential approach to the treatment of arthritis. Annals of the Rheumatic Diseases 2005, 64:1126.
129. Kanakura Y., Thompson H., Nakano T., Yamamura T., Asai H., Kitamura Y., et al. Multiple bidirectional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells. Blood 1988, 72:877.
130. Kanamaru Y., Scandiuzzi L., Essig M., Brochetta C., Guerin-Marchand C., Tomino Y., et al. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. Journal of Immunology 2006, 176:5607.
131. Kanamaru Y., Sumiyoshi K., Ushio H., Ogawa H., Okumura K., Nakao A. Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis. Journal of Immunology 2005, 174:4193.
132. Karlson U., Pejler G., Tomasini-Johansson B., Hellman L. Extended substrate specificity of rat mast cell protease 5, a rodent α-chymase with elastase-like primary specificity. The Journal of Biological Chemistry 2003, 278:39625.
133. Kennelly R., Conneely J.B., Bouchier-Hayes D., Winter D.C. Mast cells in tissue healing: From skin to the gastrointestinal tract. Current Pharmaceutical Design 2011, 17:3772.
134. Khan A.I., Horii Y., Tiuria R., Sato Y., Nawa Y. Mucosal mast cells and the expulsive mechanisms of mice against Strongyloides venezuelensis. International Journal for Parasitology 1993, 23:551.
135. Kim Y.S., Ko H.M., Kang N.I., Song C.H., Zhang X., Chung W.C., et al. Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-α in a murine model of asthma. European Journal of Immunology 2007, 37:1107.
136. Kim C.E., Lim S.K., Kim J.S. In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer. Journal of Controlled Release 2012, 157:190.
137. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annual Review of Immunology 1989, 7:59.
138. Klein S., Seidler B., Kettenberger A., Sibaev A., Rohn M., Feil R., et al. Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activity. Nature Communications 2013, 4:1630.
139. Kneilling M., Hultner L., Pichler B.J., Mailhammer R., Morawietz L., Solomon S., et al. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis and Rheumatism 2007, 56:1806.
140. Knight P.A., Wright S.H., Lawrence C.E., Paterson Y.Y., Miller H.R. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. The Journal of Experimental Medicine 2000, 192:1849.
141. Kobayashi T., Miura T., Haba T., Sato M., Serizawa I., Nagai H., et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. Journal of Immunology 2000, 164:3855.
142. Komai-Koma M., Brombacher F., Pushparaj P.N., Arendse B., McSharry C., Alexander J., et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy 2012, 67:1118-1126.
143. Koyama K., Ito Y. Mucosal mast cell responses are not required for protection against infection with the murine nematode parasite Trichuris muris. Parasite Immunology 2000, 22:13.
144. Krishna M.T., Chauhan A., Little L., Sampson K., Hawksworth R., Mant T., et al. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. The Journal of Allergy and Clinical Immunology 2001, 107:1039.
145. Krishnamoorthy N., Oriss T.B., Paglia M., Fei M., Yarlagadda M., Vanhaesebroeck B., et al. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nature Medicine 2008, 14:565.
146. Kung T.T., Stelts D., Zurcher J.A., Jones H., Umland S.P., Kreutner W., et al. Mast cells modulate allergic pulmonary eosinophilia in mice. American Journal of Respiratory Cell and Molecular Biology 1995, 12:404.
147. Lal S., Malhotra S., Gribben D., Hodder D. Nedocromil sodium: A new drug for the management of bronchial asthma. Thorax 1984, 39:809.
148. Lantz C.S., Boesiger J., Song C.H., Mach N., Kobayashi T., Mulligan R.C., et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998, 392:90.
149. Latour S., Bonnerot C., Fridman W.H., Daeron M. Induction of tumor necrosis factor-α production by mast cells via FcγR. Role of the FcγRIII γ subunit. The Journal of Immunology 1992, 149:2155.
150. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689.
151. Lee Y.M., Jippo T., Kim D.K., Katsu Y., Tsujino K., Morii E., et al. Alteration of protease expression phenotype of mouse peritoneal mast cells by changing the microenvironment as demonstrated by in situ hybridization histochemistry. The American Journal of Pathology 1998, 153:931.
152. Li L., Li Y., Reddel S.W., Cherrian M., Friend D.S., Stevens R.L., et al. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. Journal of Immunology 1998, 161:5079.
153. -sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. Journal of Immunology 2011, 187:274.
154. fl/fl mice. Blood 2011, 118:6930.
155. Lin L., Bankaitis E., Heimbach L., Li N., Abrink M., Pejler G., et al. Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid. The Journal of Biological Chemistry 2011, 286:37358.
156. Liu J., Divoux A., Sun J., Zhang J., Clement K., Glickman J.N., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nature Medicine 2009, 15:940.
157. Lukacs N.W., Strieter R.M., Lincoln P.M., Brownell E., Pullen D.M., Schock H.J., et al. Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. Journal of Immunology 1996, 156:3945.
158. Lunderius-Andersson C., Enoksson M., Nilsson G. Mast cells respond to cell injury through the recognition of IL-33. Frontiers in Immunology 2012, 3:82.
159. Magnusson S.E., Pejler G., Kleinau S., Abrink M. Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis. The FASEB Journal 2009, 23:875.
160. Malaviya R., Abraham S.N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. Journal of Leukocyte Biology 2000, 67:841.
161. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996, 381:77.
162. Malaviya R., Navara C., Uckun F.M. Role of Janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria. Immunity 2001, 15:313.
163. Mallen-St Clair J., Pham C.T., Villalta S.A., Caughey G.H., Wolters P.J. Mast cell dipeptidyl peptidase I mediates survival from sepsis. The Journal of Clinical Investigation 2004, 113:628.
164. Mancardi D.A., Jonsson F., Iannascoli B., Khun H., Van Rooijen N., Huerre M., et al. Cutting edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis. Journal of Immunology 2011, 186:1899.
165. Manova K., Bachvarova R.F. Expression of c-kit encoded at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts. Developmental Biology 1991, 146:312.
166. Manova K., Nocka K., Besmer P., Bachvarova R.F. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 1990, 110:1057.
167. Marichal T., Starkl P., Reber L.L., Kalesnikoff J., Oettgen H.C., Tsai M., et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 2013, 39:963.
168. Martin T.R., Takeishi T., Katz H.R., Austen K.F., Drazen J.M., Galli S.J. Mast cell activation enhances airway responsiveness to methacholine in the mouse. The Journal of Clinical Investigation 1993, 91:1176.
169. Maurer M., Echtenacher B., Hultner L., Kollias G., Mannel D.N., Langley K.E., et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. The Journal of Experimental Medicine 1998, 188:2343.
170. Maurer M., Wedemeyer J., Metz M., Piliponsky A.M., Weller K., Chatterjea D., et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004, 432:512.
171. McLachlan J.B., Hart J.P., Pizzo S.V., Shelburne C.P., Staats H.F., Gunn M.D., et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nature Immunology 2003, 4:1199.
172. McLachlan J.B., Shelburne C.P., Hart J.P., Pizzo S.V., Goyal R., Brooking-Dixon R., et al. Mast cell activators: A new class of highly effective vaccine adjuvants. Nature Medicine 2008, 14:536.
173. Mekori Y.A., Chang J.C., Wershil B.K., Galli S.J. Studies of the role of mast cells in contact sensitivity responses. Passive transfer of the reaction into mast cell-deficient mice locally reconstituted with cultured mast cells: Effect of reserpine on transfer of the reaction with DNP-specific cloned T cells. Cellular Immunology 1987, 109:39.
174. d mice. Journal of Immunology 1985, 135:879.
175. Metcalfe D.D., Peavy R.D., Gilfillan A.M. Mechanisms of mast cell signaling in anaphylaxis. The Journal of Allergy and Clinical Immunology 2009, 124:639.
176. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526.
177. W-sh "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells. Journal of Immunology 2013, 190:5534.
178. Milenkovic N., Frahm C., Gassmann M., Griffel C., Erdmann B., Birchmeier C., et al. Nociceptive tuning by stem cell factor/c-Kit signaling. Neuron 2007, 56:893.
179. 1-dependent passive anaphylaxis. The Journal of Clinical Investigation 1997, 99:901.
180. Molinari J.F., Moore W.R., Clark J., Tanaka R., Butterfield J.H., Abraham W.M. Role of tryptase in immediate cutaneous responses in allergic sheep. Journal of Applied Physiology 1995, 79:1966.
181. Molinari J.F., Scuri M., Moore W.R., Clark J., Tanaka R., Abraham W.M. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. American Journal of Respiratory and Critical Care Medicine 1996, 154:649.
182. Moon T.C., St Laurent C.D., Morris K.E., Marcet C., Yoshimura T., Sekar Y., et al. Advances in mast cell biology: New understanding of heterogeneity and function. Mucosal Immunology 2010, 3:111.
183. Motakis E., Guhl S., Ishizu Y., Itoh M., Kawaji H., de Hoon M., et al. Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. Blood 2014, 123:e58.
184. Mukai K., Matsuoka K., Taya C., Suzuki H., Yokozeki H., Nishioka K., et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005, 23:191.
185. Musch W., Wege A.K., Mannel D.N., Hehlgans T. Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis 2008, 46:163.
186. Muzumdar M.D., Tasic B., Miyamichi K., Li L., Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007, 45:593.
187. Nabe T., Kijitani Y., Kitagawa Y., Sakano E., Ueno T., Fujii M., et al. Involvement of chymase in allergic conjunctivitis of guinea pigs. Experimental Eye Research 2013, 113:74.
188. sh mutation on mouse chromosome 5 is associated with an inversion. Human Molecular Genetics 1995, 4:2073.
189. H2 cytokine production in an asthma model in mice. The Journal of Allergy and Clinical Immunology 2007, 120:48.
190. Nakano N., Nishiyama C., Kanada S., Niwa Y., Shimokawa N., Ushio H., et al. Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood 2007, 109:4846.
191. Nakano T., Sonoda T., Hayashi C., Yamatodani A., Kanayama Y., Yamamura T., et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. The Journal of Experimental Medicine 1985, 162:1025.
192. Nauta A.C., Grova M., Montoro D.T., Zimmermann A., Tsai M., Gurtner G.C., et al. Evidence that mast cells are not required for healing of splinted cutaneous excisional wounds in mice. PLoS One 2013, 8:e59167.
193. Nelissen S., Vangansewinkel T., Geurts N., Geboes L., Lemmens E., Vidal P.M., et al. Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4. Neurobiology of Disease 2013, 62C:260.
194. Newlands G.F., Miller H.R., MacKellar A., Galli S.J. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N brasiliensis infection. Blood 1995, 86:1968.
195. Ng M.F. The role of mast cells in wound healing. International Wound Journal 2010, 7:55.
196. Nigrovic P.A., Binstadt B.A., Monach P.A., Johnsen A., Gurish M., Iwakura Y., et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:2325.
197. sh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. The American Journal of Pathology 2008, 173:1693.
198. Nigrovic P.A., Lee D.M. Synovial mast cells: Role in acute and chronic arthritis. Immunological Reviews 2007, 217:19.
199. 41 and W. The EMBO Journal 1990, 9:1805.
200. Nogami M., Suko M., Okudaira H., Miyamoto T., Shiga J., Ito M., et al. Experimental pulmonary eosinophilia in mice by Ascaris suum extract. The American Review of Respiratory Disease 1990, 141:1289.
201. Norman M.U., Hwang J., Hulliger S., Bonder C.S., Yamanouchi J., Santamaria P., et al. Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. The American Journal of Pathology 2008, 172:1638.
202. Norris A.A. Pharmacology of sodium cromoglycate. Clinical and Experimental Allergy 1996, 26(Suppl. 4):5.
203. Ogawa M., Matsuzaki Y., Nishikawa S., Hayashi S., Kunisada T., Sudo T., et al. Expression and function of c-kit in hemopoietic progenitor cells. The Journal of Experimental Medicine 1991, 174:63.
204. Oh S.W., Pae C.I., Lee D.K., Jones F., Chiang G.K., Kim H.O., et al. Tryptase inhibition blocks airway inflammation in a mouse asthma model. Journal of Immunology 2002, 168:1992.
205. Ohnmacht C., Voehringer D. Basophils protect against reinfection with hookworms independently of mast cells and memory Th2 cells. Journal of Immunology 2010, 184:344.
206. Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Letters 2001, 502:53.
207. Oka T., Kalesnikoff J., Starkl P., Tsai M., Galli S.J. Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Laboratory Investigation 2012, 92:1472.
208. Okayama Y., Kawakami T. Development, migration, and survival of mast cells. Immunologic Research 2006, 34:97.
209. Okayama Y., Kirshenbaum A.S., Metcalfe D.D. Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells: Up-regulation by IFN-γ. Journal of Immunology 2000, 164:4332.
210. Oku Y., Itayama H., Kamiya M. Expulsion of Trichinella spiralis from the intestine of W/Wv mice reconstituted with haematopoietic and lymphopoietic cells and origin of mucosal mast cells. Immunology 1984, 53:337.
211. Okudaira H., Nogami M., Matsuzaki G., Dohi M., Suko M., Kasuya S., et al. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. International Archives of Allergy and Applied Immunology 1991, 94:171.
212. Oliveira S.H., Lukacs N.W. Stem cell factor: A hemopoietic cytokine with important targets in asthma. Current Drug Targets. Inflammation and Allergy 2003, 2:313.
213. Oliveira S.H., Taub D.D., Nagel J., Smith R., Hogaboam C.M., Berlin A., et al. Stem cell factor induces eosinophil activation and degranulation: Mediator release and gene array analysis. Blood 2002, 100:4291.
214. Orinska Z., Maurer M., Mirghomizadeh F., Bulanova E., Metz M., Nashkevich N., et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nature Medicine 2007, 13:927.
215. v mice that are genetically deficient in mast cells. The Journal of Experimental Medicine 1987, 165:615.
216. Otsuka A., Kubo M., Honda T., Egawa G., Nakajima S., Tanizaki H., et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One 2011, 6:e25538.
217. Oyamada S., Bianchi C., Takai S., Chu L.M., Sellke F.W. Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion. The Journal of Pharmacology and Experimental Therapeutics 2011, 339:143.
218. Paniagua R.T., Sharpe O., Ho P.P., Chan S.M., Chang A., Higgins J.P., et al. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. The Journal of Clinical Investigation 2006, 116:2633.
219. Paton W.D. Compound 48/80: A potent histamine liberator. British Journal of Pharmacology and Chemotherapy 1951, 6:499.
220. Pejler G., Åbrink M., Ringvall M., Wernersson S. Mast cell proteases. Advances in Immunology 2007, 95:167.
221. Pemberton A.D., Brown J.K., Wright S.H., Knight P.A., McPhee M.L., McEuen A.R., et al. Purification and characterization of mouse mast cell proteinase-2 and the differential expression and release of mouse mast cell proteinase-1 and -2 in vivo. Clinical and Experimental Allergy 2003, 33:1005.
222. Pereira P.J., Bergner A., Macedo-Ribeiro S., Huber R., Matschiner G., Fritz H., et al. Human β-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 1998, 392:306.
223. Peters E.M., Maurer M., Botchkarev V.A., Jensen K., Welker P., Scott G.A., et al. Kit is expressed by epithelial cells in vivo. The Journal of Investigative Dermatology 2003, 121:976.
224. W-sh/W-sh mice. Laboratory Investigation 2011, 91:627.
225. W-sh/W-sh mice. The American Journal of Pathology 2010, 176:926.
226. Piliponsky A.M., Chen C.C., Nishimura T., Metz M., Rios E.J., Dobner P.R., et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nature Medicine 2008, 14:392.
227. Piliponsky A.M., Chen C.C., Rios E.J., Treuting P.M., Lahiri A., Abrink M., et al. The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis. The American Journal of Pathology 2012, 181:875.
228. Ramos L., Pena G., Cai B., Deitch E.A., Ulloa L. Mast cell stabilization improves survival by preventing apoptosis in sepsis. Journal of Immunology 2010, 185:709.
229. Reber L., Da Silva C.A., Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. European Journal of Pharmacology 2006, 533:327.
230. Reber L.L., Daubeuf F., Pejler G., Abrink M., Frossard N. Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase/mast cell protease 4-dependent mechanism. Journal of Immunology 2014, 192:1847.
231. Reber L.L., Marichal T., Galli S.J. New models for analyzing mast cell functions in vivo. Trends in Immunology 2012, 33:613.
232. Reber L.L., Marichal T., Mukai K., Kita Y., Tokuoka S.M., Roers A., et al. Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice. The Journal of Allergy and Clinical Immunology 2013, 132:881.
233. Reber L., Marichal T., Sokolove J., Starkl P., Gaudenzio N., Iwakura Y., et al. Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice. Arthritis and Rheumatology 2014, 66:2881-2891.
234. Reuter S., Heinz A., Sieren M., Wiewrodt R., Gelfand E.W., Stassen M., et al. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. The European Respiratory Journal 2008, 31:773.
235. Ribatti D., Crivellato E. Mast cells, angiogenesis and cancer. Advances in Experimental Medicine and Biology 2011, 716:270.
236. Rivera J., Fierro N.A., Olivera A., Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Advances in Immunology 2008, 98:85.
237. Rodewald H.R., Feyerabend T.B. Widespread immunological functions of mast cells: Fact or fiction?. Immunity 2012, 37:13.
238. Ronnberg E., Johnzon C.F., Calounova G., Faroldi G.G., Grujic M., Hartmann K., et al. Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal Staphylococcus aureus infection in vivo. Immunology 2014, 143:155-163.
239. Rothschild A.M. Mechanisms of histamine release by compound 48-80. British Journal of Pharmacology 1970, 38:253.
240. Sakaguchi M., Takai S., Jin D., Okamoto Y., Muramatsu M., Kim S., et al. A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters. European Journal of Pharmacology 2004, 493:173.
241. Sasaki Y., Yoshimoto T., Maruyama H., Tegoshi T., Ohta N., Arizono N., et al. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. The Journal of Experimental Medicine 2005, 202:607.
242. Sawaguchi M., Tanaka S., Nakatani Y., Harada Y., Mukai K., Matsunaga Y., et al. Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness. Journal of Immunology 2012, 188:1809.
243. Sayed B.A., Walker M.E., Brown M.A. Cutting edge: Mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. Journal of Immunology 2011, 186:3294.
244. Scandiuzzi L., Beghdadi W., Daugas E., Abrink M., Tiwari N., Brochetta C., et al. Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. Journal of Immunology 2010, 185:624.
245. Schäfer B., Piliponsky A.M., Oka T., Song C.H., Gerard N.P., Gerard C., et al. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. The Journal of Allergy and Clinical Immunology 2012, 131:541-548.
246. Schemann M., Kugler E.M., Buhner S., Eastwood C., Donovan J., Jiang W., et al. The mast cell degranulator compound 48/80 directly activates neurons. PLoS One 2012, 7:e52104.
247. Schmidt-Supprian M., Rajewsky K. Vagaries of conditional gene targeting. Nature Immunology 2007, 8:665.
248. Schneider L.A., Schlenner S.M., Feyerabend T.B., Wunderlin M., Rodewald H.R. Molecular mechanism of mast cell-mediated innate defense against endothelin and snake venom sarafotoxin. The Journal of Experimental Medicine 2007, 204:2629.
249. Scholten J., Hartmann K., Gerbaulet A., Krieg T., Muller W., Testa G., et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Research 2008, 17:307.
250. Secor V.H., Secor W.E., Gutekunst C.A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. The Journal of Experimental Medicine 2000, 191:813.
251. Serafin W.E., Dayton E.T., Gravallese P.M., Austen K.F., Stevens R.L. Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker. Journal of Immunology 1987, 139:3771.
252. Sharma N., Kumar V., Everingham S., Mali R.S., Kapur R., Zeng L.F., et al. SH2 domain-containing phosphatase 2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice. Molecular and Cellular Biology 2012, 32(14):2653-2663.
253. Shelburne C.P., Nakano H., St John A.L., Chan C., McLachlan J.B., Gunn M.D., et al. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host & Microbe 2009, 6:331.
254. .heparin complexes. Journal of Immunology 2009, 182:647.
255. Shin K., Watts G.F., Oettgen H.C., Friend D.S., Pemberton A.D., Gurish M.F., et al. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. Journal of Immunology 2008, 180:4885.
256. V mice. International Archives of Allergy and Immunology 2010, 151:80.
257. Smit J.J., Willemsen K., Hassing I., Fiechter D., Storm G., van Bloois L., et al. Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses. PLoS One 2011, 6:e28917.
258. Soucek L., Lawlor E.R., Soto D., Shchors K., Swigart L.B., Evan G.I. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nature Medicine 2007, 13:1211.
259. Steimer D.A., Boyd K., Takeuchi O., Fisher J.K., Zambetti G.P., Opferman J.T. Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function. Blood 2009, 113:2805.
260. + T cell effector functions. Immunity 2009, 31:665.
261. Stevens R.L., Friend D.S., McNeil H.P., Schiller V., Ghildyal N., Austen K.F. Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:128.
262. Stevens R.L., Qui D., McNeil H.P., Friend D.S., Hunt J.E., Austen K.F., et al. Transgenic mice that possess a disrupted mast cell protease 5 (mMCP-5) gene can not store carboxypeptidase A (mMC-CPA) protein in their granules. The FASEB Journal 1996, 10:17772.
263. Stokman G., Stroo I., Claessen N., Teske G.J., Weening J.J., Leemans J.C., et al. Stem cell factor expression after renal ischemia promotes tubular epithelial survival. PLoS One 2010, 5:e14386.
264. Strait R.T., Morris S.C., Yang M., Qu X.W., Finkelman F.D. Pathways of anaphylaxis in the mouse. The Journal of Allergy and Clinical Immunology 2002, 109:658.
265. Sun J., Arias K., Alvarez D., Fattouh R., Walker T., Goncharova S., et al. Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses. Journal of Immunology 2007, 179:6696.
266. Sun J., Zhang J., Lindholt J.S., Sukhova G.K., Liu J., He A., et al. Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation 2009, 120:973.
267. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. The Journal of Clinical Investigation 2002, 109:1351.
268. Sutherland R.E., Olsen J.S., McKinstry A., Villalta S.A., Wolters P.J. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. Journal of Immunology 2008, 181:5598.
269. Suto H., Nakae S., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cell-associated TNF promotes dendritic cell migration. Journal of Immunology 2006, 176:4102.
270. Suzuki R., Leach S., Liu W., Ralston E., Scheffel J., Zhang W., et al. Molecular editing of cellular responses by the high-affinity receptor for IgE. Science 2014, 343:1021.
271. Taghon T., Yui M.A., Rothenberg E.V. Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nature Immunology 2007, 8:845.
272. Takagi K., Okuda-Ashitaka E., Mabuchi T., Katano T., Ohnishi T., Matsumura S., et al. Involvement of stem cell factor and its receptor tyrosine kinase c-kit in pain regulation. Neuroscience 2008, 153:1278.
273. Takato H., Yasui M., Ichikawa Y., Waseda Y., Inuzuka K., Nishizawa Y., et al. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice. Experimental Lung Research 2011, 37:101.
274. Takeda K., Hamelmann E., Joetham A., Shultz L.D., Larsen G.L., Irvin C.G., et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. The Journal of Experimental Medicine 1997, 186:449.
275. Takeishi T., Martin T.R., Katona I.M., Finkelman F.D., Galli S.J. Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. The Journal of Clinical Investigation 1991, 88:598.
276. Takeuchi K., Koike K., Kamijo T., Ishida S., Nakazawa Y., Kurokawa Y., et al. STI571 inhibits growth and adhesion of human mast cells in culture. Journal of Leukocyte Biology 2003, 74:1026.
277. Tanzola M.B., Robbie-Ryan M., Gutekunst C.A., Brown M.A. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. Journal of Immunology 2003, 171:4385.
278. Taube C., Wei X., Swasey C.H., Joetham A., Zarini S., Lively T., et al. Mast cells, Fc€RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. Journal of Immunology 2004, 172:6398.
279. Tchougounova E., Pejler G., Abrink M. The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. The Journal of Experimental Medicine 2003, 198:423.
280. Thakurdas S.M., Melicoff E., Sansores-Garcia L., Moreira D.C., Petrova Y., Stevens R.L., et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. The Journal of Biological Chemistry 2007, 282:20809.
281. Timoshanko J.R., Kitching A.R., Semple T.J., Tipping P.G., Holdsworth S.R. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. Journal of the American Society of Nephrology 2006, 17:150.
282. Tomimori Y., Muto T., Saito K., Tanaka T., Maruoka H., Sumida M., et al. Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice. European Journal of Pharmacology 2003, 478:179.
283. Tremaine W.J., Brzezinski A., Katz J.A., Wolf D.C., Fleming T.J., Mordenti J., et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Alimentary Pharmacology & Therapeutics 2002, 16:407.
284. Tsai M., Grimbaldeston M.A., Yu M., Tam S.Y., Galli S.J. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo. Chemical Immunology and Allergy 2005, 87:179.
285. Tsai M., Shih L.S., Newlands G.F., Takeishi T., Langley K.E., Zsebo K.M., et al. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. The Journal of Experimental Medicine 1991, 174:125.
286. Tsai M., Takeishi T., Thompson H., Langley K.E., Zsebo K.M., Metcalfe D.D., et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:6382.
287. Tsujimura Y., Obata K., Mukai K., Shindou H., Yoshida M., Nishikado H., et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008, 28:581.
288. Tsunemi K., Takai S., Nishimoto M., Jin D., Sakaguchi M., Muramatsu M., et al. A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters. The Journal of Pharmacology and Experimental Therapeutics 2004, 309:879.
289. Vaali K., Lappalainen J., Lin A.H., Mayranpaa M.I., Kovanen P.T., Berstad A., et al. Imatinib mesylate alleviates diarrhea in a mouse model of intestinal allergy. Neurogastroenterology and Motility 2012, 24:e325.
290. Voehringer D., Liang H.E., Locksley R.M. Homeostasis and effector function of lymphopenia-induced "memory-like" T cells in constitutively T cell-depleted mice. Journal of Immunology 2008, 180:4742.
291. Voehringer D., Shinkai K., Locksley R.M. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004, 20:267.
292. Waern I., Jonasson S., Hjoberg J., Bucht A., Abrink M., Pejler G., et al. Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation. Journal of Immunology 2009, 183:6369.
293. Waern I., Lundequist A., Pejler G., Wernersson S. Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. Mucosal Immunology 2013, 6:911.
294. Wastling J.M., Knight P., Ure J., Wright S., Thornton E.M., Scudamore C.L., et al. Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the β-chymase, mouse mast cell protease-1. The American Journal of Pathology 1998, 153:491.
295. Watanabe N., Tomimori Y., Saito K., Miura K., Wada A., Tsudzuki M., et al. Chymase inhibitor improves dermatitis in NC/Nga mice. International Archives of Allergy and Immunology 2002, 128:229.
296. Weidner N., Austen K.F. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathology Research and Practice 1993, 189:156.
297. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. Journal of Leukocyte Biology 1997, 61:233.
298. Weller K., Foitzik K., Paus R., Syska W., Maurer M. Mast cells are required for normal healing of skin wounds in mice. The FASEB Journal 2006, 20:2366.
299. Wernersson S., Pejler G. Mast cell secretory granules: Armed for battle. Nature Reviews Immunology 2014, 14:478-494. Published online 06 June.
300. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. Journal of Immunology 1987, 139:2605.
301. Wershil B.K., Murakami T., Galli S.J. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. Journal of Immunology 1988, 140:2356.
302. Wershil B.K., Wang Z.S., Gordon J.R., Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. The Journal of Clinical Investigation 1991, 87:446.
303. Wiener Z., Buzas E., Kovacs P., Csaba G., Szabo D., Kittel A., et al. Highly reduced peritoneal mast cell number and decreased c-kit expression in histidine decarboxylase knock out mice. Inflammation Research 2001, 50(Suppl. 2):S55.
304. Willenborg S., Eckes B., Brinckmann J., Krieg T., Waisman A., Hartmann K., et al. Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis. The Journal of Investigative Dermatology 2014, 134(7):2005-2015.
305. Williams C.M., Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. The Journal of Experimental Medicine 2000, 192:455.
306. W-sh sash mice. Clinical and Experimental Allergy 2005, 35:82.
307. Wong G.W., Foster P.S., Yasuda S., Qi J.C., Mahalingam S., Mellor E.A., et al. Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase γ. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor α/signal transducer and activator of transcription (STAT) 6-dependent pathway. The Journal of Biological Chemistry 2002, 277:41906.
308. Wong G.W., Tang Y., Feyfant E., Sali A., Li L., Li Y., et al. Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension. The Journal of Biological Chemistry 1999, 274:30784.
309. Wright C.D., Havill A.M., Middleton S.C., Kashem M.A., Dripps D.J., Abraham W.M., et al. Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-{4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy}-pentane (AMG-126737). Biochemical Pharmacology 1999, 58:1989.
310. Wulff B.C., Parent A.E., Meleski M.A., DiPietro L.A., Schrementi M.E., Wilgus T.A. Mast cells contribute to scar formation during fetal wound healing. The Journal of Investigative Dermatology 2012, 132:458.
311. Wyss D., Bonneau O., Trifilieff A. Mast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammation. British Journal of Pharmacology 2005, 145:845.
312. Xu X., Zhang D., Lyubynska N., Wolters P.J., Killeen N.P., Baluk P., et al. Mast cells protect mice from Mycoplasma pneumonia. American Journal of Respiratory and Critical Care Medicine 2006, 173:219.
313. Yagi R., Tanaka S., Motomura Y., Kubo M. Regulation of the Il4 gene is independently controlled by proximal and distal 3' enhancers in mast cells and basophils. Molecular and Cellular Biology 2007, 27:8087.
314. Younan G., Suber F., Xing W., Shi T., Kunori Y., Abrink M., et al. The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5. Journal of Immunology 2010, 185:7681.
315. Yu M., Eckart M.R., Morgan A.A., Mukai K., Butte A.J., Tsai M., et al. Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. The Journal of Clinical Investigation 2011, 121:3133.
316. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. The Journal of Clinical Investigation 2006, 116:1633.
317. Zhang Y., Ramos B.F., Jakschik B.A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992, 258:1957.
318. Zhang J., Sun J., Lindholt J.S., Sukhova G.K., Sinnamon M., Stevens R.L., et al. Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation. Circulation Research 2011, 108:1316.
319. Zhou P., Qian L., Bieszczad C.K., Noelle R., Binder M., Levy N.B., et al. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood 1998, 92:3226.
320. W-sh mice does not impair antibody-mediated arthritis. The Journal of Experimental Medicine 2007, 204:2797.